QTc Interval ECG Study with Moxifloxacin

• Research type

  Research Study

• Full title

  A randomized, double-blinded, 2-way crossover, placebo-controlled study to investigate the influence of a single-dose of moxifloxacin on the QTc interval in healthy male and female subjects for positive control validation in selected centers of the PATENT-1 trial

• IRAS ID

  25802

• Sponsor organisation

  Bayer Healthcare AG

• Eudract number

  2009-012363-34

• ISRCTN Number

  n.a

• Clinicaltrials.gov Identifier

  n.a

• Research summary

  N/A

• REC name

  East of England - Cambridge East Research Ethics Committee

• REC reference

  09/H0304/76

• Date of REC Opinion

  8 Dec 2009

• REC opinion

  Further Information Favourable Opinion